Dermapharm Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Dermapharm Holding SE engages in the off-patent branded pharmaceuticals business in Germany and internationally. It offers products for the treatment of inflammatory skin diseases, allergic reactions, disorders of the gastrointestinal tract, cardiovascular disorders and metabolic diseases. Furthermore, it offers active pharmaceutical ingredients that are used for further manufacturing of prescription drugs.
Key slides for Dermapharm Holding SE
Q2 2023
Dermapharm Holding SE
Q4 2022
Dermapharm Holding SE
Latest articles
Webull vs Robinhood: Which Platform Suits You?
In the competitive world of online trading platforms, Webull and Robinhood have emerged as two of the top choices for investors.
24 Nov 2023
Norway's Sovereign Wealth Fund: Transforming Oil Wealth into Lasting Prosperity
But what makes Norway’s striking of oil so fundamentally different from its worse faring counterparts? The answer is in large part its Norwegian Government Pension fund, and Norges Bank Investment Management
24 Nov 2023
Danaher Business System and Acquisition History
Since the early 1990s, Danaher's management team has transformed a group of under-performing industrial manufacturing companies into a global powerhouse in life sciences and diagnostics.
22 Nov 2023
Ticker symbol
DMP
Country
🇩🇪 Germany